ASCP and ASH Partner on Grant to Enhance and Expand MDS Curriculum
Oct 30, 2014
The American Society for Clinical Pathology (ASCP) and the American Society of Hematology (ASH) announced today that the two organizations are partnering on an independent educational grant from Summit, N.J.-based Celgene Corporation to update, enhance and expand ASCP’s existing Myelodysplastic Syndromes (MDS) curriculum. This represents the second independent educational grant award by Celgene to ASCP for this program. The curriculum titled, “The Diagnosis, Classification, and Clinical Care of MDS (DC3-MDS),” was developed in 2012 from the first educational grant by Celgene.
ASH Pairs Hematologists from Developing and Developed Nations for Global Training Program
Oct 29, 2014
The American Society of Hematology (ASH) today
announced the 20 hematologists and other medical professionals selected to
participate in the 2014 ASH Visitor Training Program. This program provides
talented hematologists, scientists, and laboratory staff from developing
countries the opportunity to receive training on a specific area of hematology
from an ASH member located anywhere in the world for up to 12 weeks. The goal
of this program is to build hematology capacity in developing countries and
ultimately improve the care of patients with blood diseases worldwide.
The American Society of Hematology Elects New Leadership
Oct 14, 2014
The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, today announced the election of four new members to its Executive Committee, the governing body of the organization, for terms beginning after the 2014 ASH Annual Meeting December 6-9 in San Francisco.